Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.89 USD | +2.37% | +19.69% | +5.23% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.23% | 18.64M | |
+9.80% | 106B | |
+1.03% | 104B | |
+6.72% | 23.25B | |
-13.70% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.53% | 16.99B | |
+7.92% | 14.26B | |
+39.67% | 12.76B |
- Stock Market
- Equities
- NRBO Stock
- News NeuroBo Pharmaceuticals, Inc.
- NeuroBo Gets FDA Clearance For DA-1726 Trial in Obesity; Shares Soar